Pre-treatment functional MRI of breast cancer: T2* evaluation at 3  T and relationship to dynamic contrast-enhanced and diffusion-weighted imaging

Baseline T2* relaxation time has been proposed as an imaging biomarker in cancer, in addition to Dynamic Contrast-Enhanced (DCE) MRI and diffusion-weighted imaging (DWI) parameters. The purpose of the current work is to investigate sources of error in T2* measurements and the relationship between T2* and DCE and DWI functional parameters in breast cancer.

Source: Magnetic Resonance Imaging - May 31, 2018 Category: Radiology Authors: Evanthia Kousi, Elizabeth A.M. O'Flynn, Marco Borri, Veronica A. Morgan, Nandita M. de Souza, Maria A. Schmidt Source Type: research